Perceptive Advisors - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$6,037,000
-9.5%
270,000
-10.0%
0.08%
+5.6%
Q4 2020$6,672,000300,0000.07%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,600,000$52,272,0008.55%
Foresite Capital Management IV, LLC 875,000$12,705,0007.06%
Aisling Capital Management LP 1,025,000$14,883,0006.13%
Saturn V Capital Management LP 807,969$11,731,7104.91%
Eversept Partners, LP 2,596,245$37,697,4773.19%
ACUTA CAPITAL PARTNERS, LLC 297,035$4,312,9482.89%
Paradigm Biocapital Advisors LP 2,390,077$34,703,9182.36%
DAFNA Capital Management LLC 458,373$6,655,5762.07%
SPHERA FUNDS MANAGEMENT LTD. 773,061$11,224,8462.04%
PFM Health Sciences, LP 2,715,235$39,425,2121.86%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders